Skip to main content
Immunology logoLink to Immunology
. 1977 Jun;32(6):1017–1025.

Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

J F Borel, C Feurer, C Magnée, H Stähelin
PMCID: PMC1445439  PMID: 328380

Abstract

The fungus metabolite cyclosporin A is a small cyclic peptide acting as a novel antilymphocytic agent. It is effective following either parenteral or oral administration in mice, rats and guinea-pigs. The suppressive effect after short and prolonged treatment on plaque-forming cells, the inhibition of the secondary humoral response and the reversibility of its effect on haemagglutinin formation is demonstrated. Cyclosporin A inhibits delayed hypersensitivity skin reaction to oxazolone (primary and secondary responses) in mice and to tuberculin in guinea-pigs. Its failure to suppress antibody synthesis to lipopolysaccharide antigens in nude mice suggests a selective effect on T cells. High doses of the compound affect the haemopoietic tissues very weakly as shown by the bone marrow and stem cell numbers in mice, which finding markedly contrasts with most other immunosuppressive and cytostatic drugs.

Full text

PDF
1017

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson B., Blomgren H. Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol. 1971 Oct;2(5):411–424. doi: 10.1016/0008-8749(71)90052-9. [DOI] [PubMed] [Google Scholar]
  2. Borel J. F. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology. 1976 Oct;31(4):631–641. [PMC free article] [PubMed] [Google Scholar]
  3. Borel J. F. Comparison of the immune response to sheep erythrocytes, tetanus toxoid and endotoxin in different strains of mice. Agents Actions. 1974 Oct;4(4):277–285. doi: 10.1007/BF01965231. [DOI] [PubMed] [Google Scholar]
  4. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  5. Dietrich F. M., Hess R. Hypersensitivity in mice. I. Induction of contact sensitivity to oxazolone and inhibition by various chemical compounds. Int Arch Allergy Appl Immunol. 1970;38(3):246–259. [PubMed] [Google Scholar]
  6. Floersheim G. L. Pharmakologische Beeinflussbarkeit cellulärer Immunität. Z Naturwiss Med Grundlagenforsch. 1965 Oct;2(4):307–360. [PubMed] [Google Scholar]
  7. Petcher T. J., Weber H., Rüegger A. Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. Helv Chim Acta. 1976 Jun 14;59(5):1480–1489. doi: 10.1002/hlca.19760590509. [DOI] [PubMed] [Google Scholar]
  8. Rüegger A., Kuhn M., Lichti H., Loosli H. R., Huguenin R., Quiquerez C., von Wartburg A. Cyclosporin A, ein immunsuppressiv wirksamer Peptidmetabolit aus Trichoderma polysporum (Link ex Pers.) Rifai. Helv Chim Acta. 1976;59(4):1075–1092. doi: 10.1002/hlca.19760590412. [DOI] [PubMed] [Google Scholar]
  9. TAKATSY G. The use of spiral loops in serological and virological micro-methods. Acta Microbiol Acad Sci Hung. 1955;3(1-2):191–202. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES